Catherine Gerard
Quebec, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Removal of the GAA repeat in the heart of a Friedreich's ataxia mouse model using CjCas9.
Journal: Gene therapy
Published: November 15, 2022
Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 23, 2021
A promising mouse model for Friedreich Ataxia progressing like human patients.
Journal: Behavioural brain research
Published: December 23, 2021
Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTag.
Journal: Molecular therapy. Nucleic acids
Published: March 28, 2018
Sensorimotor skills in Fxn KO/Mck mutants deficient for frataxin in muscle.
Journal: Brain research
Published: November 28, 2014
Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
Journal: Journal of molecular cell biology
Published: July 09, 2014
An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models.
Journal: Molecular therapy. Methods & clinical development
Published: January 01, 2014
A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins.
Journal: Molecular therapy. Nucleic acids
Published: May 29, 2013
AG490 improves the survival of human myoblasts in vitro and in vivo.
Journal: Cell transplantation
Published: September 12, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026